Date(s) - 29 Oct 2019 until 29 Oct 2019
9:00 AM - 10:30 AM
KOL Luncheon: Breast Cancer Molecular Diagnostics
Hosted by HTG, the event will feature a presentation by Adam Brufsky, MD, PhD (Co-Director, Comprehensive Breast Cancer Center and Medical Director, Woman’s Cancer Center at the UPMC Magee Women’s Hospital, Pittsburgh PA), who will discuss the current challenges in diagnosing breast cancer and unmet medical needs and optimizing treatment. Dr. Brufsky will be available to answer questions at the conclusion of the event.
HTG Molecular Diagnostics’ management team will provide an update of their development plan to build a comprehensive breast cancer diagnostic platform. This plan will showcase the product roadmap and milestones demonstrating the company’s progresses towards assays that can help clinicians improve the care of cancer patients.
Tuesday, October 29, 2019
12:00 – 1:30 PM EDT | 9 -10:30 AM AZ/MST
Register here for live webcast